Culturing of cells for others for scientific research purposes; custom design and engineering of cell lines; drug discovery services; laboratory research in the field of pharmaceuticals; scientific research information in the field of drug screening, namely, testing drug compounds against cells.

Pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy predication and analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits or does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes.

Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, medical consultancy and medical advisory services; individual medical counseling services provided to patients; providing information in the fields of oncology and precision medicine via a website; providing medical information to medical professionals in the form of reports in the fields of oncology and precision medicine.

Pharmaceutical, medical and veterinary preparations; pharmaceutical and medical preparations for treatment, prevention and alleviation of cancer; pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; biological preparations for medical and veterinary purposes; antibodies; chemical preparations for therapeutic use; reagents for medical diagnosis, drug-tailored efficacy prediction and/or analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes.

Technological research and consultation services, namely, in the medical and pharmaceutical research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, patient responder identification, and indication finding; industrial analysis and research services, namely, industrial research in the field of oncology biomarkers and predictive modeling; basic medical research and medical clinical research, hereunder for development of therapeutics using biomarkers and predictive modeling; drug discovery services in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers and indication finding; consultancy in the field of pharmaceutical research and development services in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarkers, patient responder identification, pharmacodynamic biomarkers and indication finding; medical research related to treatment, prevention and alleviation of cancer in the medical and pharmaceutical research fields of drug-tailored efficacy-predictive biomarks, patient responder identification, pharmacodynamic biomarkers and indication finding; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction using biomarkers and predictive modeling; medical research, namely, analysis related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction using biomarkers and predictive modeling.